ValuEngine Downgrades GlaxoSmithKline plc (GSK) to Hold

ValuEngine Downgrades GlaxoSmithKline plc (GSK) to Hold


GSK has been the topic of several other research reports. Zacks Investment Research lowered GlaxoSmithKline plc from a "hold" rating to a "sell" rating in a research report on Monday, April 17th.



from Biotech News